Biochemical Control With Radiotherapy Improves Overall Survival in Intermediate and High-Risk Prostate Cancer Patients Who Have an Estimated 10-Year Overall Survival of >90%

Article ID	Journal	Published Year	Pages	File Type
8226251	International Journal of Radiation OncologyBiologyPhysics	2012	6 Pages	PDF

Abstract

Biochemical control translates into improved overall survival in patients with high or intermediate risk disease and an estimated 10-year overall survival of >90%.

Keywords

overall survival Radiotherapy Prostate cancer Comorbidity Biochemical control

Related Topics

Physical Sciences and Engineering Physics and Astronomy Radiation

Preview

Biochemical Control With Radiotherapy Improves Overall Survival in Intermediate and High-Risk Prostate Cancer Patients Who Have an Estimated 10-Year Overall Survival of >90%

Authors

Christopher F.R.C.R., Mitchell F.R.C.P.C., Scott F.R.C.P.C., W. James F.R.C.P.C., Michel Ph.D., Mandip F.R.C.R., Winkle F.R.C.P.C., Vitali Ph.D., Thomas F.R.C.P.C.,